Filter announcements
Loading...
The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).
Astec LifeSciences has clarified regarding recent significant stock price movements, confirming that it has consistently disclosed all necessary events and information to the stock exchanges. The company has explicitly confirmed that there are no undisclosed developments, pending events, or material information requiring mandatory disclosure at this time. Management remains committed...
Astec LifeSciences Limited has clarified that it has disclosed all necessary information impacting share prices to the stock exchanges as required. Addressing a recent significant increase in trading volume, the company has confirmed that no undisclosed events or pending developments exist that require mandatory disclosure. Management assures shareholders that the...
Astec LifeSciences has set record dates for the maturity payment of its Commercial Papers (CPs). Investors holding CPs with ISINs INE563J14DO8, INE563J14DP5, and INE563J14DQ3 will receive their Rs. 25 Cr maturity amounts. The record dates are September 18, 2026, September 16, 2026, and October 12, 2026, respectively, for payments due...
Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication